ATE27269T1 - Strahlenschutzmittel mit aminothioalkyl-struktur und verfahren zu ihrer herstellung. - Google Patents

Strahlenschutzmittel mit aminothioalkyl-struktur und verfahren zu ihrer herstellung.

Info

Publication number
ATE27269T1
ATE27269T1 AT84401296T AT84401296T ATE27269T1 AT E27269 T1 ATE27269 T1 AT E27269T1 AT 84401296 T AT84401296 T AT 84401296T AT 84401296 T AT84401296 T AT 84401296T AT E27269 T1 ATE27269 T1 AT E27269T1
Authority
AT
Austria
Prior art keywords
radical
aminothioalkyl
production
compound
thiol group
Prior art date
Application number
AT84401296T
Other languages
German (de)
English (en)
Inventor
Joel Oiry
Jean-Louis Imbach
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE27269T1 publication Critical patent/ATE27269T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C07F9/1651—Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AT84401296T 1983-06-22 1984-06-21 Strahlenschutzmittel mit aminothioalkyl-struktur und verfahren zu ihrer herstellung. ATE27269T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8310318A FR2549051B1 (fr) 1983-06-22 1983-06-22 Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procede pour leur preparation
EP84401296A EP0131500B1 (fr) 1983-06-22 1984-06-21 Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procédé pour leur préparation

Publications (1)

Publication Number Publication Date
ATE27269T1 true ATE27269T1 (de) 1987-06-15

Family

ID=9290052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84401296T ATE27269T1 (de) 1983-06-22 1984-06-21 Strahlenschutzmittel mit aminothioalkyl-struktur und verfahren zu ihrer herstellung.

Country Status (8)

Country Link
US (1) US4816482A (cg-RX-API-DMAC10.html)
EP (1) EP0131500B1 (cg-RX-API-DMAC10.html)
JP (1) JPS60501605A (cg-RX-API-DMAC10.html)
AT (1) ATE27269T1 (cg-RX-API-DMAC10.html)
CA (1) CA1248298A (cg-RX-API-DMAC10.html)
DE (1) DE3463766D1 (cg-RX-API-DMAC10.html)
FR (1) FR2549051B1 (cg-RX-API-DMAC10.html)
WO (1) WO1985000167A1 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746505A (en) * 1985-04-26 1988-05-24 President And Fellows Of Harvard College Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands
FR2654617B1 (fr) * 1989-11-20 1993-10-08 Oreal Composition cosmetique reductrice pour permanente contenant, en tant qu'agent reducteur, de l'aletheine ou l'un de ses sels, et son utilisation dans un procede de deformation permanente des cheveux.
US5643966A (en) * 1990-07-06 1997-07-01 University Of New Mexico β-alethine as anti-tumor agent
US6245561B1 (en) 1990-07-06 2001-06-12 University Of New Mexico β-alethine use in cell culture and therapy
FR2676441B1 (fr) * 1991-05-17 1994-10-28 Oreal Nouveaux alkylamino-mercaptoalkylamides ou l'un de leurs sels cosmetiquement acceptables, et leur utilisation en tant qu'agents reducteurs, dans un procede de deformation permanente des cheveux.
WO1993016991A1 (es) * 1992-02-28 1993-09-02 Consejo Superior Investigaciones Científicas Tensioactivos cationicos que contienen en su molecula un grupo disulfuro, su procedimiento de obtencion
US5498616A (en) * 1994-11-04 1996-03-12 Cephalon, Inc. Cysteine protease and serine protease inhibitors
PT848011E (pt) 1996-12-16 2001-08-30 Staat Nl Verteg Door Min Welzi Metodo para acoplar polisacaridos a proteinas
BR0007437A (pt) 1999-01-08 2001-11-20 Procter & Gamble Composições tópicas que compreendem tióisfuncionais protegidos
US6703007B2 (en) * 1999-01-08 2004-03-09 The Procter & Gamble Company Topical compositions comprising functional nucleophiles protected by phosphorus-containing moieties
KR101579095B1 (ko) * 2008-07-16 2015-12-21 엘지전자 주식회사 세탁물 처리기기
US9468612B2 (en) 2011-10-26 2016-10-18 Seattle Children's Hospital Cysteamine in the treatment of fibrotic disease
SG10201800159QA (en) 2011-11-22 2018-02-27 Univ California Cysteamine and/or cystamine for treating ischemic injury
CN115724779B (zh) * 2021-09-01 2024-03-29 四川大学 酰胺烷二硫化合物、其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2574996A (en) * 1948-11-18 1951-11-13 Eastman Kodak Co N-(acetylmercaptoacetyl)-n'-n-butylurea
GB710216A (en) * 1952-05-12 1954-06-09 Parke Davis & Co Improvements in or relating to the production of organic disulphides

Also Published As

Publication number Publication date
WO1985000167A1 (fr) 1985-01-17
EP0131500B1 (fr) 1987-05-20
EP0131500A1 (fr) 1985-01-16
CA1248298A (fr) 1989-01-03
JPS60501605A (ja) 1985-09-26
US4816482A (en) 1989-03-28
JPH0523260B2 (cg-RX-API-DMAC10.html) 1993-04-02
DE3463766D1 (en) 1987-06-25
FR2549051A1 (fr) 1985-01-18
FR2549051B1 (fr) 1986-05-16

Similar Documents

Publication Publication Date Title
DE3463766D1 (en) Radioprotector agents with an aminothioalkyl structure, and process for their preparation
AU551239B2 (en) Substituted acyl derivatives of 1,2,3,4-tetrahydro isoquinoline-3-carboxylic acids
ATE133667T1 (de) Thiazolderivate, verfahren zur ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
CA2083606A1 (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
ATE137763T1 (de) Peptid-verbindungen, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung
ATE131173T1 (de) Fluorierte gallensäure-derivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen daraus.
IE830662L (en) 2-AZASPIRO £4.(3+n)|-3-CARBOXYLIC ACIDS.
DE69315827D1 (de) Neue acylierte phospholipid-arzneimittel
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
PT92540A (pt) Processo para a preparacao de derivados de anfotericina b
ES2183816T3 (es) Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
RU93019277A (ru) Раствор для защиты и лечения заболеваний и повреждения роговицы "визитон"
SE8400629L (sv) Basiska oximetrar
ES8402819A1 (es) Procedimiento para la produccion de una 3,3-dialquil-o 3,3-dialquileno-indolina.
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.
JPS55151555A (en) Proline derivatives and their production
DK168284D0 (da) Troponderivater
ES8303405A1 (es) Procedimiento de preparacion de derivados de quinidina.
DE3889532D1 (de) Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie.
FR2302734A1 (fr) Carbamates de benzimidazolyle favorisant la regression de troubles ou maladies neoplastiques
JPS5645499A (en) Glucosamine derivative and its preparation
JPS5219637A (en) Preparation of novel biscarboxylic acid esters
MX9503625A (es) Metodo para reducir el daño por radicales libres en celulas de mamiferos vivos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee